
Daewoong Pharmaceutical Expands Middle East Presence with Kuwaiti Export Agreement for Premium Botulinum Toxin ‘Nabota’
Daewoong Pharmaceutical announced on July 25th that its premium botulinum toxin, ‘Nabota,’ has secured an export contract to Kuwait, further strengthening its position in the Middle Eastern market. This deal marks Daewoong’s fifth entry into the Middle …